Organisation paid for research Program year 2025 Source: CMS Open Payments

Juno Research North Houston

Neither a doctor nor a teaching hospital

Research payments

$571,754

189 payments

Through program year 2025, Juno Research North Houston is reported as receiving $571,754 in research payments, across 189 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2025	Research	$139,854	179
2024	Research	$413,766	6
2023	Research	$18,133	4

Breakdown

Who paid Research payments · program years 2023–2025

Boehringer Ingelheim Pharmaceuticals, Inc. $529,965 45 payments
Boehringer Ingelheim International GmbH $41,789 144 payments

Studies the money was for Research payments · program years 2023–2025

phase III efficacy for obesity - with T2DM $214,038 3 payments
Phase III efficacy for obesity - without T2DM $199,728 3 payments
A Phase 3, randomised, double-blind, parallel-group, 76-week, efficacy and safety study of BI 456906 administered subcutaneously compared with placebo in participants with overweight or obesity and type 2 diabetes mellitus $74,930 73 payments
A Phase 3, randomised, double-blind, parallel-group, 76-week, efficacy and safety study of BI 456906 administered subcutaneously compared with placebo in participants with overweight or obesity without type 2 diabetes $64,924 106 payments
Phase III efficacy for obesity without T2DM $9,173 2 payments
phase III efficacy for obesity with T2DM $8,961 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.